National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2011 (No. PB 87 of 2011)
19Variation to maximum quantity or number of units
Start here
Get a plain-English read of 19
Turn the raw legal text into a practical explanation grounded in National Health (Chemotherapy Pharmaceuticals Access Program) Special Arrangement 2011 (No. PB 87 of 2011).
19 Variation to maximum quantity or number of units
(1) If an eligible medical practitioner prescribes a supply of a chemotherapy pharmaceutical benefit that is greater than the maximum quantity or number of units permitted under section 18, the supply of a chemotherapy pharmaceutical benefit must be:
(a) if the prescription was written in accordance with paragraph 10 (1) (a) — authorised in accordance with the procedures mentioned in regulation 13 of the Regulations as modified by subsection (2); and
(b) if a medication chart was prepared in accordance with paragraph 10 (1) (b) — authorised in accordance with the procedures mentioned in section 15.
(2) A reference in regulation 13 of the Regulations to a determination in force under paragraph 85A(2)(a) of the Act is to be read as a reference to the maximum quantity or number of units of the chemotherapy pharmaceutical benefit as described in section 18.